Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4802 | 1 |
Schistosoma mansoni | plexin | 0.0059 | 0.3556 | 0.6839 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4802 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0074 | 0.4802 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0074 | 0.4802 | 0.4312 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0014 | 0 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.014 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.3556 | 0.2949 |
Brugia malayi | plexin A | 0.0069 | 0.4404 | 0.3877 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4802 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.1621 | 0.193 |
Brugia malayi | RNA binding protein | 0.0074 | 0.4802 | 0.4312 |
Brugia malayi | Plexin repeat family protein | 0.0059 | 0.3556 | 0.2949 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4802 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.014 | 1 | 1 |
Entamoeba histolytica | tyrosin kinase, putative | 0.0014 | 0 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0074 | 0.4802 | 0.4312 |
Echinococcus multilocularis | plexin a4 | 0.0069 | 0.4404 | 0.899 |
Echinococcus granulosus | plexin a4 | 0.0069 | 0.4404 | 0.899 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.4802 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0074 | 0.4802 | 0.4312 |
Loa Loa (eye worm) | plexin A | 0.0069 | 0.4404 | 0.3877 |
Schistosoma mansoni | plexin | 0.0034 | 0.1621 | 0.193 |
Echinococcus granulosus | tar DNA binding protein | 0.0074 | 0.4802 | 1 |
Onchocerca volvulus | 0.0059 | 0.3556 | 1 | |
Brugia malayi | TAR-binding protein | 0.0074 | 0.4802 | 0.4312 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0074 | 0.4802 | 0.4312 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1621 | 0.0832 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.